Cargando…

Investigation into Brazilian Palygorskite for Its Potential Use as Pharmaceutical Excipient: Perspectives and Applications

Palygorskite is an aluminum and magnesium silicate characterized by its fibrous morphology, providing it with great versatility in industrial applications, including pharmaceuticals. Although most of the reserves are in the United States, in recent years occurrences of commercially exploited deposit...

Descripción completa

Detalles Bibliográficos
Autores principales: Meirelles, Lyghia Maria Araújo, Barbosa, Raquel de Melo, Sanchez-Espejo, Rita, García-Villén, Fátima, Perioli, Luana, Viseras, César, Moura, Tulio Flavio Accioly de Lima e, Raffin, Fernanda Nervo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10381531/
https://www.ncbi.nlm.nih.gov/pubmed/37512238
http://dx.doi.org/10.3390/ma16144962
_version_ 1785080467167379456
author Meirelles, Lyghia Maria Araújo
Barbosa, Raquel de Melo
Sanchez-Espejo, Rita
García-Villén, Fátima
Perioli, Luana
Viseras, César
Moura, Tulio Flavio Accioly de Lima e
Raffin, Fernanda Nervo
author_facet Meirelles, Lyghia Maria Araújo
Barbosa, Raquel de Melo
Sanchez-Espejo, Rita
García-Villén, Fátima
Perioli, Luana
Viseras, César
Moura, Tulio Flavio Accioly de Lima e
Raffin, Fernanda Nervo
author_sort Meirelles, Lyghia Maria Araújo
collection PubMed
description Palygorskite is an aluminum and magnesium silicate characterized by its fibrous morphology, providing it with great versatility in industrial applications, including pharmaceuticals. Although most of the reserves are in the United States, in recent years occurrences of commercially exploited deposits in Brazil have been recorded, mainly in the country’s northeast region. This has motivated this study, which analyzes raw Brazilian palygorskite compared to a commercial sample (Pharmasorb(®) colloidal) to demonstrate its pharmaceutical potential. The chemical and mineral composition of the samples were evaluated for surface properties, granulometry, morphology, crystallography, thermal analysis, and spectroscopy. Raw palygorskite presented 67% purity, against 74% for Pharmasorb(®) colloidal. The percentage purity relates to the presence of contaminants, mainly carbonates and quartz (harmless under conventional conditions of pharmaceutical use). Furthermore, it was possible to confirm the chemical composition of these phyllosilicates, formed primarily of silicon, aluminum, and magnesium oxides. The crystallographic and spectroscopic profiles were consistent in both samples, showing characteristic peaks for palygorskite (2θ = 8.3°) and bands attributed to fibrous phyllosilicates below 1200 cm(−1), respectively. The thermal analysis allowed the identification of the main events of palygorskite, with slight differences between the evaluated samples: loss of water adsorbed onto the surface (~85 °C), removal of water contained in the channels (~200 °C), coordinated water loss (~475 °C), and, finally, the dehydroxylation (>620 °C). The physicochemical characteristics of raw palygorskite align with pharmacopeial specifications, exhibiting a high specific surface area (122 m(2)/g), moderately negative charge (−13.1 mV), and compliance with the required limits for heavy metals and arsenic. These favorable technical attributes indicate promising prospects for its use as a pharmaceutical ingredient in the production of medicines and cosmetics.
format Online
Article
Text
id pubmed-10381531
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-103815312023-07-29 Investigation into Brazilian Palygorskite for Its Potential Use as Pharmaceutical Excipient: Perspectives and Applications Meirelles, Lyghia Maria Araújo Barbosa, Raquel de Melo Sanchez-Espejo, Rita García-Villén, Fátima Perioli, Luana Viseras, César Moura, Tulio Flavio Accioly de Lima e Raffin, Fernanda Nervo Materials (Basel) Article Palygorskite is an aluminum and magnesium silicate characterized by its fibrous morphology, providing it with great versatility in industrial applications, including pharmaceuticals. Although most of the reserves are in the United States, in recent years occurrences of commercially exploited deposits in Brazil have been recorded, mainly in the country’s northeast region. This has motivated this study, which analyzes raw Brazilian palygorskite compared to a commercial sample (Pharmasorb(®) colloidal) to demonstrate its pharmaceutical potential. The chemical and mineral composition of the samples were evaluated for surface properties, granulometry, morphology, crystallography, thermal analysis, and spectroscopy. Raw palygorskite presented 67% purity, against 74% for Pharmasorb(®) colloidal. The percentage purity relates to the presence of contaminants, mainly carbonates and quartz (harmless under conventional conditions of pharmaceutical use). Furthermore, it was possible to confirm the chemical composition of these phyllosilicates, formed primarily of silicon, aluminum, and magnesium oxides. The crystallographic and spectroscopic profiles were consistent in both samples, showing characteristic peaks for palygorskite (2θ = 8.3°) and bands attributed to fibrous phyllosilicates below 1200 cm(−1), respectively. The thermal analysis allowed the identification of the main events of palygorskite, with slight differences between the evaluated samples: loss of water adsorbed onto the surface (~85 °C), removal of water contained in the channels (~200 °C), coordinated water loss (~475 °C), and, finally, the dehydroxylation (>620 °C). The physicochemical characteristics of raw palygorskite align with pharmacopeial specifications, exhibiting a high specific surface area (122 m(2)/g), moderately negative charge (−13.1 mV), and compliance with the required limits for heavy metals and arsenic. These favorable technical attributes indicate promising prospects for its use as a pharmaceutical ingredient in the production of medicines and cosmetics. MDPI 2023-07-12 /pmc/articles/PMC10381531/ /pubmed/37512238 http://dx.doi.org/10.3390/ma16144962 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Meirelles, Lyghia Maria Araújo
Barbosa, Raquel de Melo
Sanchez-Espejo, Rita
García-Villén, Fátima
Perioli, Luana
Viseras, César
Moura, Tulio Flavio Accioly de Lima e
Raffin, Fernanda Nervo
Investigation into Brazilian Palygorskite for Its Potential Use as Pharmaceutical Excipient: Perspectives and Applications
title Investigation into Brazilian Palygorskite for Its Potential Use as Pharmaceutical Excipient: Perspectives and Applications
title_full Investigation into Brazilian Palygorskite for Its Potential Use as Pharmaceutical Excipient: Perspectives and Applications
title_fullStr Investigation into Brazilian Palygorskite for Its Potential Use as Pharmaceutical Excipient: Perspectives and Applications
title_full_unstemmed Investigation into Brazilian Palygorskite for Its Potential Use as Pharmaceutical Excipient: Perspectives and Applications
title_short Investigation into Brazilian Palygorskite for Its Potential Use as Pharmaceutical Excipient: Perspectives and Applications
title_sort investigation into brazilian palygorskite for its potential use as pharmaceutical excipient: perspectives and applications
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10381531/
https://www.ncbi.nlm.nih.gov/pubmed/37512238
http://dx.doi.org/10.3390/ma16144962
work_keys_str_mv AT meirelleslyghiamariaaraujo investigationintobrazilianpalygorskiteforitspotentialuseaspharmaceuticalexcipientperspectivesandapplications
AT barbosaraqueldemelo investigationintobrazilianpalygorskiteforitspotentialuseaspharmaceuticalexcipientperspectivesandapplications
AT sanchezespejorita investigationintobrazilianpalygorskiteforitspotentialuseaspharmaceuticalexcipientperspectivesandapplications
AT garciavillenfatima investigationintobrazilianpalygorskiteforitspotentialuseaspharmaceuticalexcipientperspectivesandapplications
AT perioliluana investigationintobrazilianpalygorskiteforitspotentialuseaspharmaceuticalexcipientperspectivesandapplications
AT viserascesar investigationintobrazilianpalygorskiteforitspotentialuseaspharmaceuticalexcipientperspectivesandapplications
AT mouratulioflavioacciolydelimae investigationintobrazilianpalygorskiteforitspotentialuseaspharmaceuticalexcipientperspectivesandapplications
AT raffinfernandanervo investigationintobrazilianpalygorskiteforitspotentialuseaspharmaceuticalexcipientperspectivesandapplications